Authority opportunity brief
Uncover market opportunities first.
Live opportunity intelligence that helps operators track the signals shaping demand, customer priorities, competition, and growth.
Free forever. 3 minutes a day. Cancel anytime. See how it works →
Trusted by investors and partners from
Authority Coverage
500+ opportunity markets.
One weekly brief for yours.
How it works
A market signal moves.
You know first.
Subscribe to an Authority market brief, say Banking Security, and we monitor the signals around it: demand shifts, customer priorities, competitor moves, regulatory pressure, vendor launches, and expert commentary. Here's how that becomes a single weekly read.
Decision area
One specific decision area, sourced and explained before the market narrative catches up.
Built on commentary from industry leaders
Every brief is grounded in the people who actually run the market. Not generalist analysts and not LLM hallucinations.
500+
Markets covered
100+
Expert contributors
24/7
Event monitoring
How a brief is made
Tracking the signals behind the opportunities, 24/7.
Every Authority brief starts with industry leaders in the field. We monitor what they're saying, synthesize it, and ship a single weekly read.
We track what industry leaders in your market are publishing and posting.
Three voices become one coherent read.
Lands in your inbox each week.
Authority Brief · Health Tech
The Peptide Boom: How GLP-1 Cracked the Door for a New Drug Modality
Updated weekly · 12+ expert sources · GLP-1, macrocycles, oral peptides · Live since Jan 2026
500+ opportunity markets covered. New signals added every week.
New from Authority
Authority Connect
Executive introductions triggered by real-time market signals. We connect the right operators when a shift creates something urgent to discuss.
Live Introduction Example
Signal detected

Eric Topol, MD
Founder & Director, Scripps Research Translational Institute

Immanuel Lerner
CEO, PeptiMed — Peptide Therapeutics
Why this match
Compare how research institutions and commercial biotech are each navigating the GLP-1 expansion — from clinical trial design to go-to-market for next-generation peptide applications.
Subscribe to your market's opportunity brief.
Authority publishes 500+ weekly market briefs. Pick yours and we'll start sending the signals shaping demand, customer priorities, competition, and growth.
500+ opportunity markets covered. Built with Oxford AI.
Free forever. 3 minutes a day. Cancel anytime.
FAQ
Where does the intelligence come from?+
24/7 monitoring of thousands of public sources, plus first-hand interviews with industry leaders in each market.
How accurate is the intelligence?+
Every claim is traced to a primary source and verified before publication.
How often will I get the brief?+
Weekly, plus timely alerts when demand, customer priorities, competition, or growth signals materially change.







